NCBI Home Page NCBI Site Search page NCBI Guide that lists and describes the NCBI resources
Conserved domains on  [gi|1799133740|ref|NP_001364754|]
View 

NEPrilysin metallopeptidase family [Caenorhabditis elegans]

Protein Classification

gluzincin family metallopeptidase( domain architecture ID 55759)

gluzincin family metallopeptidase is a zinc-dependent peptidase that contains an HEXXH motif as part of its active site; it binds a single catalytic zinc ion which is tetrahedrally coordinated by three amino acid ligands and a water molecule that forms the nucleophile upon activation during catalysis

Gene Ontology:  GO:0008237|GO:0008270
PubMed:  7674922
SCOP:  3001975

Graphical summary

 Zoom to residue level

show extra options »

Show site features     Horizontal zoom: ×

List of domain hits

Name Accession Description Interval E-value
GluZincin super family cl14813
Gluzincin Peptidase family (thermolysin-like proteinases, TLPs) which includes peptidases M1, ...
128-691 1.23e-57

Gluzincin Peptidase family (thermolysin-like proteinases, TLPs) which includes peptidases M1, M2, M3, M4, M13, M32 and M36 (fungalysins); The Gluzincin family (thermolysin-like peptidases or TLPs) includes several zinc-dependent metallopeptidases such as M1, M2, M3, M4, M13, M32, M36 peptidases (MEROPS classification), which contain the HEXXH motif as part of their active site. Peptidases in this family bind a single catalytic zinc ion which is tetrahedrally co-ordinated by three amino acid ligands and a water molecule that forms the nucleophile on activation during catalysis. The M1 family includes aminopeptidase N (APN) and leukotriene A4 hydrolase (LTA4H). APN preferentially cleaves neutral amino acids from the N-terminus of oligopeptides and is present in a variety of human tissues and cell types. LTA4H is a bifunctional enzyme, possessing an aminopeptidase as well as an epoxide hydrolase activity such that the two activities occupy different, but overlapping sites. The M3_like peptidases include the M2_ACE, M3 or neurolysin-like family (subfamilies M3B_PepF and M3A) and M32_Taq peptidases. The M2 peptidase angiotensin converting enzyme (ACE, EC 3.4.15.1) catalyzes the conversion of decapeptide angiotensin I to the potent vasopressor octapeptide angiotensin II. ACE is a key component of the renin-angiotensin system that regulates blood pressure, thus ACE inhibitors are important for the treatment of hypertension. M3A includes thimet oligopeptidase (TOP; endopeptidase 3.4.24.15), neurolysin (3.4.24.16), and the mitochondrial intermediate peptidase; and M3B includes oligopeptidase F. The M32 family includes eukaryotic enzymes from protozoa Trypanosoma cruzi, a causative agent of Chagas' disease, and from Leishmania major, a parasite that causes leishmaniasis, making these enzymes attractive targets for drug development. The M4 family includes secreted protease thermolysin (EC 3.4.24.27), pseudolysin, aureolysin, and neutral protease as well as bacillolysin (EC 3.4.24.28) that degrade extracellular proteins and peptides for bacterial nutrition, especially prior to sporulation. Thermolysin is widely used as a nonspecific protease to obtain fragments for peptide sequencing as well as in production of the artificial sweetener aspartame. The M13 family includes neprilysin (EC 3.4.24.11) and endothelin-converting enzyme I (ECE-1, EC 3.4.24.71), which fulfill a broad range of physiological roles due to the greater variation in the S2' subsite allowing substrate specificity and are prime therapeutic targets for selective inhibition. The peptidase M36 fungalysin family includes endopeptidases from pathogenic fungi. Fungalysin hydrolyzes extracellular matrix proteins such as elastin and keratin. Aspergillus fumigatus causes the pulmonary disease aspergillosis by invading the lungs of immuno-compromised animals and secreting fungalysin that possibly breaks down proteinaceous structural barriers.


The actual alignment was detected with superfamily member cd08662:

Pssm-ID: 472708 [Multi-domain]  Cd Length: 642  Bit Score: 206.45  E-value: 1.23e-57
                          10        20        30        40        50        60        70        80
                  ....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 1799133740 128 VNPCENFHHHVCNGF---NPRKKD--------------FERLMKLI-NIQEKPDHRKAVNVVRRMLSKCaMgKTEEIHQV 189
Cdd:cd08662     1 VDPCDDFYQYACGNWlknHPIPADksswgsfselqdrnEEQLREILeEAASSAADSSAEQKAKDFYKSC-M-DEEAIEKL 78
                          90       100       110       120       130       140       150       160
                  ....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 1799133740 190 GrLSSIIlpglpfPLLNNSWTKPSdpistsnssttysYPFLTKILAHIILHNPDDAGFVGIKPSSD----SEFSLFVvkp 265
Cdd:cd08662    79 G-LKPLK------PLLDKIGGLPS-------------LDDLAAELLLALLRRLGVSLLFGLGVSPDpknsSRNILYL--- 135
                         170       180       190       200       210       220       230       240
                  ....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 1799133740 266 FSPVLTNFKFRNMYDILKRNAPESSTNGMIDL-------EFDRQRQLNDVIKLQTKLEKI----EFKADPEV----VNLT 330
Cdd:cd08662   136 GQPGLGLPDRDYYLDEENAEIREAYKKYIAKLlellgadEEEAEKLAEDVLAFETELAKIslssEELRDPEKtynpLTLA 215
                         250       260       270       280       290       300       310       320
                  ....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 1799133740 331 EIQRQMPIIDWKRLIDSWIPNGYAHLKEKVYgfNTSYYEEINAIISSTPSETIYNFLFLRF---------------SFKF 395
Cdd:cd08662   216 ELQKLAPSIDWKAYLKALGPPADDPDKVIVS--QPEYLKKLDKLLASTPLRTLKNYLIWRLldslapylskefrdaRFFY 293
                         330       340       350       360       370       380       390       400
                  ....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 1799133740 396 LRT----EVASDLEDTCLHQLSTTIP---GKivLYGSEE--PEALNLLNGMLHTIKDQLKRSLATLKWMDSRGIEEAQKK 466
Cdd:cd08662   294 GKAlsgqKEPEPRWKRCVELVNGALGealGR--LYVEKYfsEEAKADVEEMVENIKEAFKERLENLDWMDEETKKKALEK 371
                         410       420       430       440       450       460       470       480
                  ....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 1799133740 467 FNKTKTVFGF----TGEDLIDELVGKITPESNYISTLQNVLLWQTRNMFKSVAE-NNVTVFLNS--EV--FYSVEKNEIT 537
Cdd:cd08662   372 LDAMKVKIGYpdkwRDYSALDIYYDDLNVSDSYFENVLRLLRFETKRQLAKLGKpVDRTEWSMSpqTVnaYYNPSLNEIV 451
                         490       500       510       520       530       540       550       560
                  ....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 1799133740 538 ISRALLHYPFMSANLPNYTNFATIASKILPQMIHIFDERGRFYDSDGNHRNWWNTETERYFQIIVQCF----------DG 607
Cdd:cd08662   452 FPAGILQPPFFDPDAPDALNYGGIGAVIGHEITHGFDDQGRQYDENGNLRNWWTNEDRKEFEERAQCLvdqysnyevpPG 531
                         570       580       590       600       610       620       630       640
                  ....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 1799133740 608 MMQN-----------VFGVSVSigWNAY-DSTKEPYATLPGIQQSSDEALFFYSMVKTMCTSDPDN-------------- 661
Cdd:cd08662   532 LHVNgkltlgeniadNGGLRLA--YRAYkKWLKENGPELPGLEGFTPEQLFFLSFAQVWCSKYRPEalrqllltdphspg 609
                         650       660       670
                  ....*....|....*....|....*....|...
gi 1799133740 662 ---VNEALASVPQFNSAFKCNNGTKMNPPTKCK 691
Cdd:cd08662   610 kfrVNGPLSNSPEFAEAFNCPPGSPMNPEKKCR 642
 
Name Accession Description Interval E-value
M13 cd08662
Peptidase family M13 includes neprilysin and endothelin-converting enzyme I; The M13 family of ...
128-691 1.23e-57

Peptidase family M13 includes neprilysin and endothelin-converting enzyme I; The M13 family of metallopeptidases includes neprilysin (neutral endopeptidase, NEP, enkephalinase, CD10, CALLA, EC 3.4.24.11), endothelin-converting enzyme I (ECE-1, EC 3.4.24.71), erythrocyte surface antigen KELL (ECE-3), phosphate-regulating gene on the X chromosome (PHEX), soluble secreted endopeptidase (SEP), and damage-induced neuronal endopeptidase (DINE)/X-converting enzyme (XCE). Proteins in this family fulfill a broad range of physiological roles due to the greater variation in the active site's S2' subsite allowing substrate specificity. NEP is expressed in a variety of tissues including kidney and brain, and is involved in many physiological and pathological processes, including blood pressure and inflammatory response. It degrades a wide array of substrates such as substance P, enkephalins, cholecystokinin, neurotensin and somatostatin. It is an important enzyme in the regulation of amyloid-beta (Abeta) protein that forms amyloid plaques that are associated with Alzeimers disease (AD). ECE-1 catalyzes the final rate-limiting step in the biosynthesis of endothelins via post-translational conversion of the biologically inactive big endothelins. Like NEP, it also hydrolyzes bradykinin, substance P, neurotensin, and Abeta. Endothelin-1 overproduction has been implicated in various diseases including stroke, asthma, hypertension, and cardiac and renal failure. Kell is a homolog of NEP and constitutes a major antigen on human erythrocytes; it preferentially cleaves big endothelin-3 to produce bioactive endothelin-3, but is also known to cleave substance P and neurokinin A. PHEX forms a complex interaction with fibroblast growth factor 23 (FGF23) and matrix extracellular phosphoglycoprotein, causing bone mineralization. A loss-of-function mutation in PHEX disrupts this interaction leading to hypophosphatemic rickets; X-linked hypophosphatemic (XLH) rickets is the most common form of metabolic rickets. ECEL1 is a brain metalloprotease which plays a critical role in the nervous regulation of the respiratory system, while DINE is abundantly expressed in the hypothalamus and its expression responds to nerve injury. A majority of these M13 proteases are prime therapeutic targets for selective inhibition.


Pssm-ID: 341056 [Multi-domain]  Cd Length: 642  Bit Score: 206.45  E-value: 1.23e-57
                          10        20        30        40        50        60        70        80
                  ....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 1799133740 128 VNPCENFHHHVCNGF---NPRKKD--------------FERLMKLI-NIQEKPDHRKAVNVVRRMLSKCaMgKTEEIHQV 189
Cdd:cd08662     1 VDPCDDFYQYACGNWlknHPIPADksswgsfselqdrnEEQLREILeEAASSAADSSAEQKAKDFYKSC-M-DEEAIEKL 78
                          90       100       110       120       130       140       150       160
                  ....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 1799133740 190 GrLSSIIlpglpfPLLNNSWTKPSdpistsnssttysYPFLTKILAHIILHNPDDAGFVGIKPSSD----SEFSLFVvkp 265
Cdd:cd08662    79 G-LKPLK------PLLDKIGGLPS-------------LDDLAAELLLALLRRLGVSLLFGLGVSPDpknsSRNILYL--- 135
                         170       180       190       200       210       220       230       240
                  ....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 1799133740 266 FSPVLTNFKFRNMYDILKRNAPESSTNGMIDL-------EFDRQRQLNDVIKLQTKLEKI----EFKADPEV----VNLT 330
Cdd:cd08662   136 GQPGLGLPDRDYYLDEENAEIREAYKKYIAKLlellgadEEEAEKLAEDVLAFETELAKIslssEELRDPEKtynpLTLA 215
                         250       260       270       280       290       300       310       320
                  ....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 1799133740 331 EIQRQMPIIDWKRLIDSWIPNGYAHLKEKVYgfNTSYYEEINAIISSTPSETIYNFLFLRF---------------SFKF 395
Cdd:cd08662   216 ELQKLAPSIDWKAYLKALGPPADDPDKVIVS--QPEYLKKLDKLLASTPLRTLKNYLIWRLldslapylskefrdaRFFY 293
                         330       340       350       360       370       380       390       400
                  ....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 1799133740 396 LRT----EVASDLEDTCLHQLSTTIP---GKivLYGSEE--PEALNLLNGMLHTIKDQLKRSLATLKWMDSRGIEEAQKK 466
Cdd:cd08662   294 GKAlsgqKEPEPRWKRCVELVNGALGealGR--LYVEKYfsEEAKADVEEMVENIKEAFKERLENLDWMDEETKKKALEK 371
                         410       420       430       440       450       460       470       480
                  ....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 1799133740 467 FNKTKTVFGF----TGEDLIDELVGKITPESNYISTLQNVLLWQTRNMFKSVAE-NNVTVFLNS--EV--FYSVEKNEIT 537
Cdd:cd08662   372 LDAMKVKIGYpdkwRDYSALDIYYDDLNVSDSYFENVLRLLRFETKRQLAKLGKpVDRTEWSMSpqTVnaYYNPSLNEIV 451
                         490       500       510       520       530       540       550       560
                  ....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 1799133740 538 ISRALLHYPFMSANLPNYTNFATIASKILPQMIHIFDERGRFYDSDGNHRNWWNTETERYFQIIVQCF----------DG 607
Cdd:cd08662   452 FPAGILQPPFFDPDAPDALNYGGIGAVIGHEITHGFDDQGRQYDENGNLRNWWTNEDRKEFEERAQCLvdqysnyevpPG 531
                         570       580       590       600       610       620       630       640
                  ....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 1799133740 608 MMQN-----------VFGVSVSigWNAY-DSTKEPYATLPGIQQSSDEALFFYSMVKTMCTSDPDN-------------- 661
Cdd:cd08662   532 LHVNgkltlgeniadNGGLRLA--YRAYkKWLKENGPELPGLEGFTPEQLFFLSFAQVWCSKYRPEalrqllltdphspg 609
                         650       660       670
                  ....*....|....*....|....*....|...
gi 1799133740 662 ---VNEALASVPQFNSAFKCNNGTKMNPPTKCK 691
Cdd:cd08662   610 kfrVNGPLSNSPEFAEAFNCPPGSPMNPEKKCR 642
Peptidase_M13 pfam01431
Peptidase family M13; Mammalian enzymes are typically type-II membrane anchored enzymes which ...
528-692 1.37e-27

Peptidase family M13; Mammalian enzymes are typically type-II membrane anchored enzymes which are known, or believed to activate or inactivate oligopeptide (pro)-hormones such as opioid peptides. The family also contains a bacterial member believed to be involved with milk protein cleavage.


Pssm-ID: 279739 [Multi-domain]  Cd Length: 205  Bit Score: 110.58  E-value: 1.37e-27
                          10        20        30        40        50        60        70        80
                  ....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 1799133740 528 FYSVEKNEITISRALLHYPFMSANLPNYTNFATIASKILPQMIHIFDERGRFYDSDGNHRNWWNTETERYFQIIVQC--- 604
Cdd:pfam01431   3 YYQPNRNEIVFPAAILQPPFFDPNYPRAVNYGGIGNVIAHEITHGFDDQGAQFDKDGNLRSWWTDEDAEEFKDRAQClie 82
                          90       100       110       120       130       140       150       160
                  ....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 1799133740 605 -FDGMMQNVFGVS----------------VSIGWNAY---DSTKEPyaTLPGIQQSSDEALFFYSMVKTMCTSDPDN--- 661
Cdd:pfam01431  83 qYSEYTPPDGTKCangtltlgeniadlggLTIALRAYkklLSANET--VLPGFENLTPDQLFFRGAAQIWCMKQSPAevl 160
                         170       180       190       200
                  ....*....|....*....|....*....|....*....|....*
gi 1799133740 662 --------------VNEALASVPQFNSAFKCNNGTKMNPPTKCKL 692
Cdd:pfam01431 161 rqllvdphsppefrVNGVMSNMPAFYEAFNCPEGDKMNPEPRCRL 205
PepO COG3590
Predicted metalloendopeptidase [Posttranslational modification, protein turnover, chaperones];
307-684 6.53e-12

Predicted metalloendopeptidase [Posttranslational modification, protein turnover, chaperones];


Pssm-ID: 442809 [Multi-domain]  Cd Length: 674  Bit Score: 68.64  E-value: 6.53e-12
                          10        20        30        40        50        60        70        80
                  ....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 1799133740 307 DVIKLQTKLEKIEFK----ADPE----VVNLTEIQRQMPIIDWKRLIDSWipnGYAHLKEKVYGfNTSYYEEINAIISST 378
Cdd:COG3590   221 AVLALETALAKAHWSrvelRDPEktynPMTVAELAKLAPGFDWDAYLKAL---GLPAVDEVIVG-QPSFFKALDKLLAST 296
                          90       100       110       120       130       140       150       160
                  ....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 1799133740 379 PSETIYNFLflrfSFKFLRtEVASDLEDTcLHQLSTTIPGKiVLYGSEEPE-----ALNLLNGML--------------- 438
Cdd:COG3590   297 PLEDWKAYL----RWHLLD-SAAPYLSKA-FVDANFDFYGK-TLSGQKEQRprwkrAVALVNGALgealgqlyveryfpp 369
                         170       180       190       200       210       220       230       240
                  ....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 1799133740 439 ----------HTIKDQLKRSLATLKWMDSRGIEEAQKKFNKtktvfgFTgedlidELVG-----------KITPESnYIS 497
Cdd:COG3590   370 eakarmeelvANLRAAYRERIENLDWMSPETKAKALEKLAA------FT------PKIGypdkwrdysglEIKRDD-LVG 436
                         250       260       270       280       290       300       310       320
                  ....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 1799133740 498 TLQNVLLWQTRNMFKSvaennvtvfLNSEV--------------FYSVEKNEITISRALLHYPFMSANLPNYTNFATIAS 563
Cdd:COG3590   437 NVLRASAFEYQRELAK---------LGKPVdrtewgmtpqtvnaYYNPTMNEIVFPAAILQPPFFDPKADDAVNYGGIGA 507
                         330       340       350       360       370       380       390       400
                  ....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 1799133740 564 KILPQMIHIFDERGRFYDSDGNHRNWWNTE-----TERYFQIIVQcFDGmMQNVFGVSV----------------SIGWN 622
Cdd:COG3590   508 VIGHEITHGFDDQGSQFDGDGNLRNWWTPEdraafEARTKKLVAQ-YDA-YEPLPGLHVngkltlgeniadlgglSIAYD 585
                         410       420       430       440       450       460       470
                  ....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....
gi 1799133740 623 AYDSTKEpYATLPGIQQSSDEALFFYS------------MVKTMCTSDPDN-----VNEALASVPQFNSAFKCNNGTKM 684
Cdd:COG3590   586 AYKLSLK-GKEAPVIDGFTGDQRFFLGwaqvwrskardeALRQRLATDPHSpgefrVNGPVRNLDAFYEAFDVKPGDKM 663
 
Name Accession Description Interval E-value
M13 cd08662
Peptidase family M13 includes neprilysin and endothelin-converting enzyme I; The M13 family of ...
128-691 1.23e-57

Peptidase family M13 includes neprilysin and endothelin-converting enzyme I; The M13 family of metallopeptidases includes neprilysin (neutral endopeptidase, NEP, enkephalinase, CD10, CALLA, EC 3.4.24.11), endothelin-converting enzyme I (ECE-1, EC 3.4.24.71), erythrocyte surface antigen KELL (ECE-3), phosphate-regulating gene on the X chromosome (PHEX), soluble secreted endopeptidase (SEP), and damage-induced neuronal endopeptidase (DINE)/X-converting enzyme (XCE). Proteins in this family fulfill a broad range of physiological roles due to the greater variation in the active site's S2' subsite allowing substrate specificity. NEP is expressed in a variety of tissues including kidney and brain, and is involved in many physiological and pathological processes, including blood pressure and inflammatory response. It degrades a wide array of substrates such as substance P, enkephalins, cholecystokinin, neurotensin and somatostatin. It is an important enzyme in the regulation of amyloid-beta (Abeta) protein that forms amyloid plaques that are associated with Alzeimers disease (AD). ECE-1 catalyzes the final rate-limiting step in the biosynthesis of endothelins via post-translational conversion of the biologically inactive big endothelins. Like NEP, it also hydrolyzes bradykinin, substance P, neurotensin, and Abeta. Endothelin-1 overproduction has been implicated in various diseases including stroke, asthma, hypertension, and cardiac and renal failure. Kell is a homolog of NEP and constitutes a major antigen on human erythrocytes; it preferentially cleaves big endothelin-3 to produce bioactive endothelin-3, but is also known to cleave substance P and neurokinin A. PHEX forms a complex interaction with fibroblast growth factor 23 (FGF23) and matrix extracellular phosphoglycoprotein, causing bone mineralization. A loss-of-function mutation in PHEX disrupts this interaction leading to hypophosphatemic rickets; X-linked hypophosphatemic (XLH) rickets is the most common form of metabolic rickets. ECEL1 is a brain metalloprotease which plays a critical role in the nervous regulation of the respiratory system, while DINE is abundantly expressed in the hypothalamus and its expression responds to nerve injury. A majority of these M13 proteases are prime therapeutic targets for selective inhibition.


Pssm-ID: 341056 [Multi-domain]  Cd Length: 642  Bit Score: 206.45  E-value: 1.23e-57
                          10        20        30        40        50        60        70        80
                  ....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 1799133740 128 VNPCENFHHHVCNGF---NPRKKD--------------FERLMKLI-NIQEKPDHRKAVNVVRRMLSKCaMgKTEEIHQV 189
Cdd:cd08662     1 VDPCDDFYQYACGNWlknHPIPADksswgsfselqdrnEEQLREILeEAASSAADSSAEQKAKDFYKSC-M-DEEAIEKL 78
                          90       100       110       120       130       140       150       160
                  ....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 1799133740 190 GrLSSIIlpglpfPLLNNSWTKPSdpistsnssttysYPFLTKILAHIILHNPDDAGFVGIKPSSD----SEFSLFVvkp 265
Cdd:cd08662    79 G-LKPLK------PLLDKIGGLPS-------------LDDLAAELLLALLRRLGVSLLFGLGVSPDpknsSRNILYL--- 135
                         170       180       190       200       210       220       230       240
                  ....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 1799133740 266 FSPVLTNFKFRNMYDILKRNAPESSTNGMIDL-------EFDRQRQLNDVIKLQTKLEKI----EFKADPEV----VNLT 330
Cdd:cd08662   136 GQPGLGLPDRDYYLDEENAEIREAYKKYIAKLlellgadEEEAEKLAEDVLAFETELAKIslssEELRDPEKtynpLTLA 215
                         250       260       270       280       290       300       310       320
                  ....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 1799133740 331 EIQRQMPIIDWKRLIDSWIPNGYAHLKEKVYgfNTSYYEEINAIISSTPSETIYNFLFLRF---------------SFKF 395
Cdd:cd08662   216 ELQKLAPSIDWKAYLKALGPPADDPDKVIVS--QPEYLKKLDKLLASTPLRTLKNYLIWRLldslapylskefrdaRFFY 293
                         330       340       350       360       370       380       390       400
                  ....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 1799133740 396 LRT----EVASDLEDTCLHQLSTTIP---GKivLYGSEE--PEALNLLNGMLHTIKDQLKRSLATLKWMDSRGIEEAQKK 466
Cdd:cd08662   294 GKAlsgqKEPEPRWKRCVELVNGALGealGR--LYVEKYfsEEAKADVEEMVENIKEAFKERLENLDWMDEETKKKALEK 371
                         410       420       430       440       450       460       470       480
                  ....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 1799133740 467 FNKTKTVFGF----TGEDLIDELVGKITPESNYISTLQNVLLWQTRNMFKSVAE-NNVTVFLNS--EV--FYSVEKNEIT 537
Cdd:cd08662   372 LDAMKVKIGYpdkwRDYSALDIYYDDLNVSDSYFENVLRLLRFETKRQLAKLGKpVDRTEWSMSpqTVnaYYNPSLNEIV 451
                         490       500       510       520       530       540       550       560
                  ....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 1799133740 538 ISRALLHYPFMSANLPNYTNFATIASKILPQMIHIFDERGRFYDSDGNHRNWWNTETERYFQIIVQCF----------DG 607
Cdd:cd08662   452 FPAGILQPPFFDPDAPDALNYGGIGAVIGHEITHGFDDQGRQYDENGNLRNWWTNEDRKEFEERAQCLvdqysnyevpPG 531
                         570       580       590       600       610       620       630       640
                  ....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 1799133740 608 MMQN-----------VFGVSVSigWNAY-DSTKEPYATLPGIQQSSDEALFFYSMVKTMCTSDPDN-------------- 661
Cdd:cd08662   532 LHVNgkltlgeniadNGGLRLA--YRAYkKWLKENGPELPGLEGFTPEQLFFLSFAQVWCSKYRPEalrqllltdphspg 609
                         650       660       670
                  ....*....|....*....|....*....|...
gi 1799133740 662 ---VNEALASVPQFNSAFKCNNGTKMNPPTKCK 691
Cdd:cd08662   610 kfrVNGPLSNSPEFAEAFNCPPGSPMNPEKKCR 642
Peptidase_M13 pfam01431
Peptidase family M13; Mammalian enzymes are typically type-II membrane anchored enzymes which ...
528-692 1.37e-27

Peptidase family M13; Mammalian enzymes are typically type-II membrane anchored enzymes which are known, or believed to activate or inactivate oligopeptide (pro)-hormones such as opioid peptides. The family also contains a bacterial member believed to be involved with milk protein cleavage.


Pssm-ID: 279739 [Multi-domain]  Cd Length: 205  Bit Score: 110.58  E-value: 1.37e-27
                          10        20        30        40        50        60        70        80
                  ....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 1799133740 528 FYSVEKNEITISRALLHYPFMSANLPNYTNFATIASKILPQMIHIFDERGRFYDSDGNHRNWWNTETERYFQIIVQC--- 604
Cdd:pfam01431   3 YYQPNRNEIVFPAAILQPPFFDPNYPRAVNYGGIGNVIAHEITHGFDDQGAQFDKDGNLRSWWTDEDAEEFKDRAQClie 82
                          90       100       110       120       130       140       150       160
                  ....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 1799133740 605 -FDGMMQNVFGVS----------------VSIGWNAY---DSTKEPyaTLPGIQQSSDEALFFYSMVKTMCTSDPDN--- 661
Cdd:pfam01431  83 qYSEYTPPDGTKCangtltlgeniadlggLTIALRAYkklLSANET--VLPGFENLTPDQLFFRGAAQIWCMKQSPAevl 160
                         170       180       190       200
                  ....*....|....*....|....*....|....*....|....*
gi 1799133740 662 --------------VNEALASVPQFNSAFKCNNGTKMNPPTKCKL 692
Cdd:pfam01431 161 rqllvdphsppefrVNGVMSNMPAFYEAFNCPEGDKMNPEPRCRL 205
Peptidase_M13_N pfam05649
Peptidase family M13; M13 peptidases are well-studied proteases found in a wide range of ...
130-476 8.24e-17

Peptidase family M13; M13 peptidases are well-studied proteases found in a wide range of organizms including mammals and bacteria. In mammals they participate in processes such as cardiovascular development, blood-pressure regulation, nervous control of respiration, and regulation of the function of neuropeptides in the central nervous system. In bacteria they may be used for digestion of milk.


Pssm-ID: 461703  Cd Length: 382  Bit Score: 82.73  E-value: 8.24e-17
                          10        20        30        40        50        60        70        80
                  ....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 1799133740 130 PCENFHHHVCNGF---NPRKKD------FERLMKLINIQ---------EKPDHRKAVNVVRRMLSKCaMgKTEEIHQVGr 191
Cdd:pfam05649   1 PCDDFYQYACGGWlknHPIPADksswgtFDELRERNEKQlreileeaaASESDPGAVEKAKDLYKSC-M-DTDAIEKLG- 77
                          90       100       110       120       130       140       150       160
                  ....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 1799133740 192 LSSIIlpglpfPLLN-----NSWTKPSDpistsnssttysypfLTKILAHIILHNPDdaGFVGIKPSSD----SEFSLFV 262
Cdd:pfam05649  78 LKPLK------PLLDeiggpLANKDKFD---------------LLETLAKLRRYGVD--SLFGFGVGPDdknsSRNILYL 134
                         170       180       190       200       210       220       230       240
                  ....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 1799133740 263 VKP-----------------FSPVLTNFKfRNMYDILKrnapesstngMIDLEFDRQRQLNDVIKLQTKLEKI----EFK 321
Cdd:pfam05649 135 DQPglglpdrdyylkdrdekSAEIREAYK-AYIAKLLT----------LLGASEEAAALAEEVLAFETKLAKAslsrEER 203
                         250       260       270       280       290       300       310       320
                  ....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 1799133740 322 ADPE----VVNLTEIQRQMPIIDWKRLIDSWIPNgyAHLKEKVYGFNTSYYEEINAIISSTPSETIYNFLFLRF------ 391
Cdd:pfam05649 204 RDPEktynPMTLAELQKLAPGIDWKAYLNAAGLP--DVPSDEVIVSQPEYLKALSKLLAETPLRTLKNYLIWRLvrslap 281
                         330       340       350       360       370       380       390       400
                  ....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 1799133740 392 ---------SFKFLRTEVASDLED---TCLHQLSTTIP---GKivLYGSE--EPEALNLLNGMLHTIKDQLKRSLATLKW 454
Cdd:pfam05649 282 ylsdefrdaNFEFYGTLSGTKQRPrwkRCVSLVNGLLGealGR--LYVKKyfPEEAKARVEELVENIKEAFRERLDELDW 359
                         410       420
                  ....*....|....*....|..
gi 1799133740 455 MDSRGIEEAQKKFNKTKTVFGF 476
Cdd:pfam05649 360 MDEETKKKALEKLDAMTVKIGY 381
PepO COG3590
Predicted metalloendopeptidase [Posttranslational modification, protein turnover, chaperones];
307-684 6.53e-12

Predicted metalloendopeptidase [Posttranslational modification, protein turnover, chaperones];


Pssm-ID: 442809 [Multi-domain]  Cd Length: 674  Bit Score: 68.64  E-value: 6.53e-12
                          10        20        30        40        50        60        70        80
                  ....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 1799133740 307 DVIKLQTKLEKIEFK----ADPE----VVNLTEIQRQMPIIDWKRLIDSWipnGYAHLKEKVYGfNTSYYEEINAIISST 378
Cdd:COG3590   221 AVLALETALAKAHWSrvelRDPEktynPMTVAELAKLAPGFDWDAYLKAL---GLPAVDEVIVG-QPSFFKALDKLLAST 296
                          90       100       110       120       130       140       150       160
                  ....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 1799133740 379 PSETIYNFLflrfSFKFLRtEVASDLEDTcLHQLSTTIPGKiVLYGSEEPE-----ALNLLNGML--------------- 438
Cdd:COG3590   297 PLEDWKAYL----RWHLLD-SAAPYLSKA-FVDANFDFYGK-TLSGQKEQRprwkrAVALVNGALgealgqlyveryfpp 369
                         170       180       190       200       210       220       230       240
                  ....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 1799133740 439 ----------HTIKDQLKRSLATLKWMDSRGIEEAQKKFNKtktvfgFTgedlidELVG-----------KITPESnYIS 497
Cdd:COG3590   370 eakarmeelvANLRAAYRERIENLDWMSPETKAKALEKLAA------FT------PKIGypdkwrdysglEIKRDD-LVG 436
                         250       260       270       280       290       300       310       320
                  ....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 1799133740 498 TLQNVLLWQTRNMFKSvaennvtvfLNSEV--------------FYSVEKNEITISRALLHYPFMSANLPNYTNFATIAS 563
Cdd:COG3590   437 NVLRASAFEYQRELAK---------LGKPVdrtewgmtpqtvnaYYNPTMNEIVFPAAILQPPFFDPKADDAVNYGGIGA 507
                         330       340       350       360       370       380       390       400
                  ....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 1799133740 564 KILPQMIHIFDERGRFYDSDGNHRNWWNTE-----TERYFQIIVQcFDGmMQNVFGVSV----------------SIGWN 622
Cdd:COG3590   508 VIGHEITHGFDDQGSQFDGDGNLRNWWTPEdraafEARTKKLVAQ-YDA-YEPLPGLHVngkltlgeniadlgglSIAYD 585
                         410       420       430       440       450       460       470
                  ....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....
gi 1799133740 623 AYDSTKEpYATLPGIQQSSDEALFFYS------------MVKTMCTSDPDN-----VNEALASVPQFNSAFKCNNGTKM 684
Cdd:COG3590   586 AYKLSLK-GKEAPVIDGFTGDQRFFLGwaqvwrskardeALRQRLATDPHSpgefrVNGPVRNLDAFYEAFDVKPGDKM 663
 
Blast search parameters
Data Source: Precalculated data, version = cdd.v.3.21
Preset Options:Database: CDSEARCH/cdd   Low complexity filter: no  Composition Based Adjustment: yes   E-value threshold: 0.01

References:

  • Wang J et al. (2023), "The conserved domain database in 2023", Nucleic Acids Res.51(D)384-8.
  • Lu S et al. (2020), "The conserved domain database in 2020", Nucleic Acids Res.48(D)265-8.
  • Marchler-Bauer A et al. (2017), "CDD/SPARCLE: functional classification of proteins via subfamily domain architectures.", Nucleic Acids Res.45(D)200-3.
Help | Disclaimer | Write to the Help Desk
NCBI | NLM | NIH